Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma
- 1 January 2004
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 203 (2) , 225-231
- https://doi.org/10.1016/j.canlet.2003.09.036
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesionsMelanoma Research, 2003
- Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regressionMelanoma Research, 2003
- Assembly and Antigen-Presenting Function of MHC Class I Molecules in Cells Lacking the ER Chaperone CalreticulinImmunity, 2002
- Heart, Brain, and Body Wall Defects in Mice Lacking CalreticulinExperimental Cell Research, 2000
- Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAPImmunity, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Calnexin Influences Folding of Human Class I Histocompatibility Proteins but Not Their Assembly with β2-MicroglobulinJournal of Biological Chemistry, 1995
- An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide.The Journal of Experimental Medicine, 1994
- Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum.The Journal of Experimental Medicine, 1994
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984